Trial Profile
Phase II study of antineoplastons A10 and AS2-1 in patients with brain stem glioma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Antineoplaston A10/antineoplaston AS2-1 (Primary) ; Antineoplaston-A10 (Primary) ; Antineoplaston-AS2-1 (Primary)
- Indications Glioma
- Focus Therapeutic Use
- Sponsors Burzynski Research Institute
- 14 Apr 2016 Results from this trial published in Child's Nervous System in December 2014, as per Burzynski Research Institute, Inc media release.
- 16 Apr 2015 Results of subgroup analysis in patients with non-diffuse intrinsic pontine glioma published in Journal of Cancer Therapy, according to a Burzynski Research Institute media release.
- 16 Apr 2015 Results published in the Media Release.